EUVIMEDEUVIMED entdecken
Multizentrische StudieRandomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

A novel intrauterine estrogen-releasing system for preventing the postoperative recurrence of intrauterine adhesion: a multicenter randomized controlled study

Limin Feng, Yun Sun, Songying Zhang, Yonghong Qian, Suping Fang, Baojun Yang, Lizhen Xu, Jinghua Li, Yichao Niu, Shengpeng Zhang, Luping Zhang, Jianmin Chen

BMC Medicine · 16.09.2024 · 22 (1)

DOI: 10.1186/s12916-024-03608-4 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift BMC Medicine, online erschienen am 16.09.2024. Verfasst von Limin Feng und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology and Obstetrics, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. Lucyfeng1966@163.com. Hauptthemen laut MEDLINE: Estrogens. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Transcervical resection of adhesions (TCRA) is the standard treatment for intrauterine adhesion (IUA). Previous studies have shown that postoperative oral estrogen or an intrauterine physical barrier could reduce the recurrence of IUA by promoting the proliferation of the endometrium or inhibiting the reformation of adhesions. Our team designed an intrauterine stent that can release estrogen within the uterine cavity slowly. In this study, we aimed to investigate the efficacy and safety of the estrogen-releasing intrauterine system in preventing the recurrence of moderate to severe IUA. METHODS: This was a multicenter prospective randomized controlled 2-arm parallel trial that included patients who were diagnosed with moderate to severe IUA and who received TCRA. A total of 250 patients were randomly assigned, at a 1:1 ratio, to receive the intrauterine estrogen-releasing system or a Foley catheter balloon combined with oral estrogen therapy after surgery. The primary outcome was the rate of adhesion reduction in the two groups. The secondary outcomes included endometrial thickness at the ovulation period, menstrual improvement rates, and other reported adverse events during follow-up. RESULTS: The average daily drug release amount for all the tested stents was 0.21 mg/day. At 60 days postoperatively, the rate of adhesion reduction was significantly greater in the experimental group than in the control group (93.33% vs. 58.56%, p < 0.001). The endometrium of the experimental group was thicker than that of the control group (p < 0.001). Consistently, the rate of improvement in menstruation was greater in the experimental group than in the control group (p = 0.010). No grade 3-4 adverse events were found in the two groups during the 1-year follow-up. CONCLUSIONS: In the cohort of patients with moderate to severe IUA, the intrauterine estrogen-releasing system was more effective at reducing adhesion than traditional oral estrogen combined with an intrauterine Foley catheter after TCRA. This novel intrauterine system provides a new option for the management of IUA after surgery. TRIAL REGISTRATION: The registration number is NCT04972032. Date of registration: August 15, 2021.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EstrogensHumansFemaleTissue AdhesionsAdultProspective StudiesUterine DiseasesTreatment OutcomeSecondary PreventionRecurrencePostoperative Complications

Stichwörter der Autor:innen

EstrogenIntrauterine adhesionRecurrenceReleasing systemTranscervical resection of adhesions

Substanzen

Estrogens

Autor:innen und Institutionen

  • Department of Gynecology and Obstetrics, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. Lucyfeng1966@163.com.
  • Department of Gynecology and Obstetrics, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Department of Gynecology and Obstetrics, Shaw Hospital Affiliated to Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Department of Gynecology and Obstetrics, Suzhou Municipal Hospital, Suzhou, Jiangsu, China.
  • Department of Gynecology and Obstetrics, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.

Zitieren

APA

Feng, L., Sun, Y., Zhang, S., Qian, Y., Fang, S., Yang, B., Xu, L., Li, J., Niu, Y., Zhang, S., Zhang, L., & Chen, J. (2024). A novel intrauterine estrogen-releasing system for preventing the postoperative recurrence of intrauterine adhesion: a multicenter randomized controlled study. BMC Medicine, 22(1). https://doi.org/10.1186/s12916-024-03608-4

Vancouver

Feng L, Sun Y, Zhang S, Qian Y, Fang S, Yang B, et al. A novel intrauterine estrogen-releasing system for preventing the postoperative recurrence of intrauterine adhesion: a multicenter randomized controlled study. BMC Medicine. 2024;22(1). doi:10.1186/s12916-024-03608-4

BibTeX
@article{Feng2024,
  author = {Feng, Limin and Sun, Yun and Zhang, Songying and Qian, Yonghong and Fang, Suping and Yang, Baojun and Xu, Lizhen and Li, Jinghua and Niu, Yichao and Zhang, Shengpeng and Zhang, Luping and Chen, Jianmin},
  title = {A novel intrauterine estrogen-releasing system for preventing the postoperative recurrence of intrauterine adhesion: a multicenter randomized controlled study},
  journal = {BMC Medicine},
  year = {2024},
  volume = {22},
  number = {1},
  doi = {10.1186/s12916-024-03608-4}
}
Kostenlos starten →